This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Link between effectiveness and cost data
The costing was undertaken prospectively on the same patient sample as that used in the effectiveness study.
Study sample
To yield an 80% power of detecting significant differences at a 1% significance level, data on approximately 1,350 patients were required. A total of 1,417 patients were eligible and were willing to participate in the study, of which 83 failed randomisation eligibility criteria. Hence 1,334 were included into the study. For the cost-utility analysis, 1,286 (96%) of the 1,334 trial participants were included in the study. Three hundred and twenty-six patients were randomised to best care in general practice, 297 to best care plus exercise alone, 342 to best care plus manipulation alone, and 322 to best care plus manipulation and exercise. The authors did not provide the age and gender distribution for the sample used in the cost-utility analysis. However, they did provide the baseline characteristics of the study groups in the accompanying clinical paper.
Study design
The study was a pragmatic randomised controlled trial (RCT) with factorial design. It was carried out in 14 centres across the UK. After consenting participants had completed their baseline assessments, nurses contacted the remote randomisation service. This stratified participants by practice and allocated them by randomly permuted blocks. The participants were followed up for 12 months. The authors did not report the loss to follow-up for the study sample used in the cost-utility analysis. However, in the clinical paper, the authors reported a loss to follow-up ranging from 31% in the exercise group to 22% in the manipulation and exercise group receiving treatment in the NHS.
Analysis of effectiveness
The analysis of the clinical study was conducted on an intention to treat basis. The primary health outcome used in the analysis was the EQ-5D scores at baseline, 3 months and one year after randomisation. The EQ-5D measures health on five 3-point scales. More specifically, mobility, self-care, usual activities, pain-discomfort and anxiety depression. In the accompanying clinical paper the authors reported that all groups were similar in terms of their baseline characteristics.
Effectiveness results
As the results were expressed as utilities, these are presented in the health benefits field.
The authors also stated that the accompanying clinical paper reported that exercise alone achieved a small functional benefit at 3 months, but not at one year, and that manipulation achieved a small to moderate benefit at 3 months and a small benefit at one year. Combined treatment achieved a moderate benefit at 3 months and a small benefit at one year. (All these were statistically significant). No significant differences in outcome occurred between manipulation in NHS premises and private premises.
